What does Puma Biotechnology, Inc. do?
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast…
What is Puma Biotechnology, Inc.'s P/E and P/B ratio?
Puma Biotechnology, Inc. has a P/E ratio of 22.1 and a P/B ratio of 4.20.
What is Puma Biotechnology, Inc.'s debt-to-equity ratio?
Puma Biotechnology, Inc. has a debt-to-equity ratio of 0.03.
How much does Puma Biotechnology, Inc. owe compared with what it owns?
Puma Biotechnology, Inc. owes $0.28 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Puma Biotechnology, Inc.'s Positivity rank?
Puma Biotechnology, Inc. is ranked #4,398 of 6,774 companies globally and #2,186 of 4,000 in United States on PositoAI, with a Positivity Score of 19,513.
Does Puma Biotechnology, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Puma Biotechnology, Inc..
Where can I read the latest news about Puma Biotechnology, Inc.?
Recent headlines about Puma Biotechnology, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Puma Biotechnology, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Puma Biotechnology, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.